BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Mentice Inc. VIST(TM) New and Enhanced Carotid and Coronary Training Modules Take Medical Simulation Training to the Next Level


12/1/2008 9:19:08 AM

GOTHENBURG, Sweden, December 1 /PRNewswire/ -- Mentice proudly announces the launch of two new products for endovascular simulation training - the Mentice VIST 7.7 enhanced training modules for Carotid and Coronary interventions. New features such as vital signs, complications, medication management and measurement functionality add to the clinical realism and enhance the educational value of simulation training.

"Features like vital signs and complications imply a dynamic patient representation which requires further decision making, planning and patient interactions," said Goran Malmberg, President/CEO of Mentice.

"On top of the new functionalities, we are launching new anatomical content and further training alternatives such as CTO (Chronic Total Occlusion) lesions and cases that enable transradial access," Malmberg continues. "This launch truly shows that Mentice continues to be a driver of the medical simulation market and it further strengthens our position as a leader in the field of endovascular simulation training."

With the launch of the VIST 7.7 training modules Mentice adds to the already wide range of training opportunities for Carotid and Coronary interventions - all together a total of 42 patient cases. A summary of the new features are presented below.

Vital signs - All cases have vital signs recognition and response.

Complications - A select number of cases include complications that will occur as a result of user actions. One example, engaging a catheter too deeply into an ostium may result in vascular spasm.

Medication management - Medication administration is included to manage the complications the trainees encounter. One example of this would be the injection of Nitroglycerin for treatment of a spasm.

Measurement functionality - New measurement functionality has been added to allow the users to easily measure the diameters and length of lesions, reference vessels, etc - adding additional realism to the equipment selection process.

Mentice - improving patient safety

Mentice is a world leader in medical simulation, providing qualified solutions for training, education and assessment opportunities. With a focus on minimally invasive techniques and procedures, Mentice develops simulation systems for training in a safe environment within the fields of endovascular intervention and endoscopic surgery. The advantages of training with Mentice solutions are well documented enhancing clinical performance, reducing cost, and, in the long term, improving patient safety.

CONTACT: For further information, please contact Goran Malmberg,
President/CEO of Mentice. Office: +46-31-33-99-401, E-mail:
info@mentice.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES